Navigation Links
New Gene ID'd in Brittle Bone Disease
Date:1/20/2010

Discovery may shed light on origin of osteogenesis imperfecta, researchers say

WEDNESDAY, Jan. 20 (HealthDay News) -- A new gene involved in a recessive form of brittle bone disease has been pinpointed by researchers.

The gene is the third to be identified in a sequence of genes involved in previously unexplained forms of osteogenesis imperfecta, a sometimes fatal genetic condition that weakens bones, resulting in frequent fractures.

The new gene, discovered by U.S. National Institutes of Health researchers and their colleagues, is involved in the production of Cyclophilin B, which is part of a complex of three proteins that folds collagen into a precise molecular configuration before it's secreted from cells.

Collagen acts as the molecular scaffolding that holds together bone, tendons, skin and other tissues.

Most types of osteogenesis imperfecta are the result of a dominant mutation in collagen itself, requiring only one copy of the mutated gene to cause the condition, the researchers explained in an NIH news release. Osteogenesis imperfecta involving the Cyclophilin B gene is a recessive trait, requiring two defective copies of the gene to cause the disorder.

Identification of this new gene "provides insight into a previously undescribed form of osteogenesis imperfecta. The advance also provides new information on how collagen folds during normal bone formation, which may also lead to greater understanding of other bone disorders," Dr. Alan E. Guttmacher, acting director of the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development, said in the news release.

The study is published in the Jan. 20 issue of the New England Journal of Medicine.

More information

The American Academy of Orthopaedic Surgeons has more about osteogenesis imperfecta.



-- Robert Preidt



SOURCE: U.S. National Institutes of Health, news release, Jan. 20, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Do Antidepressants Make Bones Brittle?
2. Stem cell treatment for brittle bones in the womb
3. Even Mild Lung Disease Affects the Heart
4. Identified: Switch that turns on allergic disease in people
5. Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
6. Compounds Identified That Might Treat Nerve Diseases
7. Erectile Dysfunction Predicts Heart Disease
8. CARE Works With Women in Haiti to Keep Disease at Bay
9. Researchers find new insights into inherited retinal disease
10. Moderate Radiation Tied to Heart Disease, Stroke
11. Kidney-disease drug with Dartmouth origins licensed in Asia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to ... Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final ... and levels of the game, Connor Sports has committed to a significantly increased focus ...
(Date:5/26/2016)... Pompano Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... Green House® Project offering a new model of care for living and ... on three core values: Meaningful Life in a Real Home provided by Empowered Staff. ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 ... 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around the world ... Cancer Survivors Day®. , National Cancer Survivors Day® is an annual worldwide Celebration ...
(Date:5/26/2016)... ... 26, 2016 , ... Catalent Pharma Solutions, the leading global ... and global clinical supply services, today announced two key appointments and the opening ... and strategic growth plans in the Asia Pacific region. , Howard Kim has ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology: